SEC Filings

SEC Filings

Filing date	Description	Form	View
Apr 12, 2010	Simplified registration form	S-3	View HTML 0001193125-10-081531.pdf 0001193125-10-081531.rtf 0001193125-10-081531.xls
Apr 06, 2010	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001193125-10-077475.pdf 0001193125-10-077475.rtf 0001193125-10-077475.xls
Apr 06, 2010	An annual report to security holders	ARS	View HTML
Mar 29, 2010	Annual report which provides a comprehensive overview of the company for the past year	10-K	View HTML 0001193125-10-070134.pdf 0001193125-10-070134.rtf 0001193125-10-070134.xls
Mar 17, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-059576.pdf 0001193125-10-059576.rtf 0001193125-10-059576.xls
Mar 17, 2010	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001193125-10-059599.pdf 0001193125-10-059599.rtf 0001193125-10-059599.xls
Mar 15, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-057037.pdf 0001193125-10-057037.rtf 0001193125-10-057037.xls
Feb 23, 2010	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-10-036581.pdf 0001193125-10-036581.rtf 0001193125-10-036581.xls
Feb 16, 2010	An amendment to the SC 13G filing	SC 13G/A	View HTML 0000950123-10-013006.pdf 0000950123-10-013006.rtf 0000950123-10-013006.xls
Feb 16, 2010	An amendment to the SC 13G filing	SC 13G/A	View HTML 0001393825-10-000016.pdf 0001393825-10-000016.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE